Alan R. Crossman

The University of Manchester, Manchester, England, United Kingdom 
neurodegenerative disorders
"Alan Crossman"
Mean distance: 16.38 (cluster 6)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bezard E, Li Q, Hulme H, et al. (2020) µ opioid receptor agonism for L-DOPA-induced dyskinesia in Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience
Bastide MF, Meissner WG, Picconi B, et al. (2015) Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease. Progress in Neurobiology
Shariatgorji M, Nilsson A, Goodwin RJ, et al. (2014) Direct targeted quantitative molecular imaging of neurotransmitters in brain tissue sections. Neuron. 84: 697-707
Ko WK, Martin-Negrier ML, Bezard E, et al. (2014) RGS4 is involved in the generation of abnormal involuntary movements in the unilateral 6-OHDA-lesioned rat model of Parkinson's disease. Neurobiology of Disease. 70: 138-48
Kobylecki C, Burn DJ, Kass-Iliyya L, et al. (2014) Randomized clinical trial of topiramate for levodopa-induced dyskinesia in Parkinson's disease. Parkinsonism & Related Disorders. 20: 452-5
Bourdenx M, Nilsson A, Wadensten H, et al. (2014) Abnormal structure-specific peptide transmission and processing in a primate model of Parkinson's disease and l-DOPA-induced dyskinesia. Neurobiology of Disease. 62: 307-12
Obeso JA, Guridi J, Nambu A, et al. (2013) Motor manifestations and basal ganglia output activity: the paradox continues. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 416-8
Kobylecki C, Crossman AR, Ravenscroft P. (2013) Alternative splicing of AMPA receptor subunits in the 6-OHDA-lesioned rat model of Parkinson's disease and L-DOPA-induced dyskinesia. Experimental Neurology. 247: 476-84
Kobylecki C, Hill MP, Crossman AR, et al. (2011) Synergistic antidyskinetic effects of topiramate and amantadine in animal models of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 2354-63
Kobylecki C, Cenci MA, Crossman AR, et al. (2010) Calcium-permeable AMPA receptors are involved in the induction and expression of l-DOPA-induced dyskinesia in Parkinson's disease. Journal of Neurochemistry. 114: 499-511
See more...